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l e t t e r s Testicular germ cell tumor (TGCT) is the most common cancer in young men and is notable for its high familial risks 1,2 . So far, six loci associated with TGCT have been reported [3] [4] [5] [6] [7] . From genome-wide association study (GWAS) analysis of 307,291 SNPs in 986 TGCT cases and 4,946 controls, we selected for follow-up 694 SNPs, which we genotyped in a further 1,064 TGCT cases and 10,082 controls from the UK. We identified SNPs at nine new loci (1q22, 1q24.1, 3p24.3, 4q24, 5q31.1, 8q13.3, 16q12.1, 17q22 and 21q22.3) showing association with TGCT (P < 5 × 10 −8 ), which together account for an additional 4-6% of the familial risk of TGCT. The loci include genes plausibly related to TGCT development. PRDM14, at 8q13.3, is essential for early germ cell specification 8 , and DAZL, at 3p24.3, is required for the regulation of germ cell development 9 . Furthermore, PITX1, at 5q31.1, regulates TERT expression and is the third TGCT-associated locus implicated in telomerase regulation 10 .
TGCT is the most common malignancy in men aged 15-45 years 1 . Studies in families have estimated that the risk to brothers of TGCT cases is increased by 8-to 10-fold and the risk to sons of cases is increased by 4-to 6-fold, with these risks substantially higher than the equivalent familial relative risk of ~2 that is typical for common cancers such as breast, colorectal and prostate 2 . Recent GWAS of TGCT have identified eight associated SNPs at six loci, which together account for >11% of the genetic risk of TGCT [3] [4] [5] [6] [7] . These loci reside at 12q21 (encompassing KITLG), 5q31 (SPRY4), 6p21 (BAK1), 5p15 (TERT and CLPTM1L), 12p13 (ATF7IP) and 9p24 (DMRT1) 11 .
To find additional susceptibility loci for TGCT, we identified the most strongly associated 1,050 SNPs in our previous GWAS, which comprised 307,291 SNPs genotyped in 986 cases of TGCT and 4,946 controls from the UK 3, 4 . These SNPs were included on a custom Illumina iSelect genotyping array (the iCOGS array). The iCOGS array includes 211,155 cancer-related SNPs selected for further evaluation in different cancers and has already yielded 70 new susceptibility loci for breast, ovarian and prostate cancers 12, 13 . Using the iCOGS array, we genotyped 1,094 TGCT cases from the UK who had not been included in the original GWAS. We compared these genotypes to those of three cancer-free UK control series, also genotyped on the iCOGS array. After quality control exclusions, we obtained data for 694 of the 1,050 SNPs in 1,064 cases and 10,082 controls (iCOGS replication series).
We tested association between each SNP and TGCT risk using a 1-degree-of-freedom trend test, adjusted for six principal components. Genomic control, quantified using 36,879 uncorrelated SNPs not related to TGCT, showed evidence of only modest inflation of the test statistics (λ = 1.14, λ 1000 = 1.07; after adjustment for six principal components, λ = 1.05, λ 1000 = 1.02; Supplementary Fig. 1 ). There was clear evidence of association of the six previously reported loci in the iCOGS replication series (P trend = 2.43 × 10 −8 to 9.31 × 10 −28 ), with odds ratios (ORs) consistent with those previously published (Supplementary Table 1) .
In a combined fixed-effects meta-analysis of the GWAS and the adjusted iCOGS replication for the remaining 640 SNPs outside of these 6 loci, we identified association at P < 5 × 10 −8 for an additional 18 SNPs at 9 loci: 1q22, 1q24.1, 3p24.3, 4q24, 5q31.1, 8q13.3, 16q12.1, 17q22 and 21q22.3 ( Fig. 1) . After multiple logistic regression to test for independence of effects, there was one SNP remaining at each of the nine loci showing association with TGCT ( Table 1) . The associations at 1q24.1 and 17q22 have been replicated concurrently in other independent TGCT series 14, 15 .
For each SNP, we tested for evidence of departure from a log-additive (multiplicative) model. Only rs2072499 at 1q22 showed evidence of departure from the log-additive model, indicating a recessive effect (heterozygote OR (OR het ) = 1.00 (95% confidence interval (CI) = 0.87-1.16); homozygote OR (OR hom ) = 1.53 (95% CI = 1.27-1.84); l e t t e r s 2-degrees-of-freedom P = 5.18 × 10 −6 ; Supplementary Table 2) . This observation was supported by genotypic (2-degrees-of-freedom) analysis of the GWAS data for rs2072499 (OR het = 1.09 (95% CI = 0.94-1.26); OR hom = 1.64 (95% CI = 1.24-2.01); 2-degrees-offreedom P = 1.25 × 10 −6 ). We found no evidence for statistical interaction between any pair of these nine newly associated SNPs or of these SNPs with the eight previously identified SNPs; for every combination of SNPs, the combined risk was consistent with the product of the individual risks.
We investigated whether the newly identified loci were associated with different risks in subgroups of TGCT cases characterized by specific phenotypic characteristics (Supplementary Tables 3-5 ). Consistent with our findings at the six previously identified loci, none of the newly identified loci showed a significant difference in effect when comparing cases of the two TGCT histological subtypes, seminoma and nonseminoma. Likewise, there was no clear evidence of differential association by age of diagnosis, presence of testicular maldescent, family history of TGCT or unilateral versus bilateral disease, although the power to detect differences in effect was limited by the case distribution.
Encyclopedia of DNA Elements (ENCODE) data indicated that rs2072499, rs3790672, rs3805663, rs7010162, rs9905704 and rs2839186 may have effects on transcription, on the basis of evidence of their location within a DNase I hypersensitivity site, local modification of histones, indicating promoter or enhancer activity, influence on binding of transcription factors and/or effect on a regulatory motif. Functional annotations from the ENCODE data for all correlated variants within each of the nine linkage disequilibrium (LD) blocks (r 2 > 0.8) are shown in Supplementary Table 6 . We then investigated whether the genotype at each of these nine SNPs was associated with differential expression of the genes lying within 500 kb of the SNP: there were no compelling patterns evident from expression data available for fibroblast, skin, adipose and lymphoblastoid cells (Supplementary Table 7 ). Further examination in testicular germ cells for evidence of effects on transcriptional regulation and gene expression would be of interest.
Evidence supports the idea that TGCT develops from primordial germ cells or gonocytes, with tumor initiation described in utero, via a preinvasive stage termed intratubular germ cell neoplasia unclassified (IGCNU) or carcinoma in situ (CIS) 16 . It is therefore noteworthy that a number of the genes within the loci identified in this study relate to pathways of early differentiation and development in testicular germ cells 11 (Fig. 1) .
rs10510452 lies in an LD block of 82 kb at 3p24.3 that contains only one gene, DAZL (deleted in azoospermia like). DAZL encodes an RNA-binding protein that has been shown in expression studies in human primordial germ cells to have a central role in the early differentiation of primordial germ cells 17 . Dazl-null mice are infertile,
Observed (-log P)
Recombination rate (cM/Mb) 80 npg l e t t e r s with differentiation of the germ cells halted at the type A spermatogonia stage 9 , and expression of DAZ1 is testis specific 18, 19 . Sequence analysis indicates that the DAZ1 gene cluster on the Y chromosome arose during primate evolution via transposition of the DAZL gene 20 .
Of note, DAZ1 has been implicated as the critical gene within the Y-chromosome AZF (azoospermia factor) region, so named because deletions of this region cause non-obstructive spermatogenetic failure (azoospermia) in humans 21 . rs7010162 lies in an LD block of 61 kb at 8q13.3 in which there is one gene, PRDM14, that is required for both the reacquisition of pluripotency and the genome-wide epigenetic reprogramming that are necessary for primordial germ cell specification 8, 22, 23 . PRDM14 encodes a transcriptional regulator that controls the expression of key pluripotency genes, such as POU5F1 (OCT4), NANOG and SOX2, which are highly expressed in IGCNU and TGCT 24, 25 . Although PRDM14 expression is normally restricted to germ cell and stem cell lineages, amplification and/or overexpression of PRDM14 has been reported in a number of different cancer types, including TGCT [26] [27] [28] [29] .
rs3805663 is located in a LD block of 51 kb at 5q31.1 that contains two genes, CATSPER3 and PITX1. CATSPER3 (cation channel, sperm associated 3) is one of a family of genes that together form a functional heterotetrameric cation channel, exclusively expressed in testis and essential for the hyperactivated motility of differentiated germ cells (spermatozoa); accordingly, Catsper3-null male mice are completely infertile [30] [31] [32] . An equally plausible candidate gene at this locus is PITX1 (paired-like homeodomain transcription factor 1), with the encoded protein binding to specific PITX1-binding sites in the promoter region of TERT, thus regulating the expression of telomerase 10 . Thus, along with the previously identified TGCT-associated loci at 5p15 (TERT) and 12p13 (ATF7IP, which regulates the expression of TERT), the signal at 5q31.1 may also be mediated via effects on telomerase regulation. Whereas the 5p15 (TERT) region is notable for its associations with multiple cancers [33] [34] [35] [36] [37] [38] [39] , so far, there have been no associations reported with other cancers for the loci at 5q31.1 (PITX1) and 12p13 (ATF7IP). rs9905704 lies at 17q22 in an LD block of 813 kb containing several genes, including RAD51C and TEX14 (testis expressed 14). TEX14 encodes a protein kinase that is highly expressed in human male germ cells 40, 41 . Male Tex14 -null mice are infertile, whereas female Tex14 -null mice have normal fertility 42 . Cellular studies have shown that TEX14 regulates the kinetochore-microtubule assembly and spindle checkpoint in germ cells of the testis and requires recruitment of key proteins such as CENPE, a kinesin-like motor protein that associates with the centromere [41] [42] [43] . It is thus noteworthy that CENPE (centromere-associated protein E) is located within the 214-kb TGCTassociated LD block at 4q24. Furthermore, PMF1, one of the two genes located in the TGCT-associated region at 1q22, is part of the MIS12 complex that is required for normal chromosome alignment, segregation and kinetochore formation during mitosis 44 . Therefore, regulation of microtubule assembly may be the mechanism linking the signals at 17q22, 4q24 and 1q22.
In summary, we have identified 9 new loci for TGCT, bringing the total number of TGCT-associated loci identified so far to 15. These loci have provided considerable new insights into testicular germ cell tumorigenesis, implicating genes involved in germ cell specification and/or differentiation (DAZL and PRDM14), including the KIT-KITL signaling pathway (KITL, SPRY4 and BAK1) and genes involved in sex determination (DMRT1), microtubule assembly (TEX14, CENPE and PMF1) and telomerase regulation (TERT, ATF7IP and PITX1). The nine new susceptibility alleles account for ~4% of the excess familial risk to brothers of men with TGCT and ~6% of the excess familial risk to sons of men with TGCT, bringing the cumulative totals to ~15% and ~22%, respectively. The power to detect these loci in this combined analysis was modest (29-84%); accordingly, there are likely to be several additional loci for TGCT of equivalent or lesser effect, which may be identifiable via even larger follow-up studies of these data and meta-analyses with other GWAS data. Moreover, imputation and fine-scale association mapping of the loci may uncover more of the missing heritability, either through identifying more strongly associated variants or by identifying additional signals, including rare variants, at these loci. Integration of these genetic variants together with non-genetic TGCT risk factors into risk models may enable clinically useful risk profiling for TGCT in unaffected men, which in turn may provide a rational basis for applying strategies for the screening and targeted prevention of TGCT. 
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Methods and any associated references are available in the online version of the paper. 4 , such that SNPs on both sex chromosomes were included in the current analysis. We used data on 314,861 SNPs that were successfully genotyped on both arrays. We excluded individuals with low call rate (<95%), with abnormal autosomal heterozygosity or with >10% non-European ancestry (based on multidimensional scaling). We filtered out all SNPs with (i) minor allele frequency (MAF) of <1%; (ii) a call rate of <95% in cases or controls; (iii) MAF of 1-5% and a call rate of <99%; or (iv) deviation from Hardy-Weinberg equilibrium (P of <1 × 10 −12 in controls and <1 × 10 −5 in cases). In total, 307,291 SNPs passed the quality control filters, and we put forward for replication the 1,050 SNPs with the lowest P values (P < 1.3 × 10 −3 ), based on the 1-degree-of-freedom Cochran-Armitage trend test.
iCOGS genotyping. Genotyping was conducted using a custom Illumina Infinium array (iCOGS array) comprising 211,155 SNPs selected across multiple consortia within COGS (Collaborative Oncological Gene-environment Study; see ref.
12 for details of SNP inclusion). Of the 1,050 SNPs submitted from our analysis, 740 attained an Illumina design score of ≥0.8 and were included on the array. Genotyping was performed at Génome Québec, one of the seven genotyping centers providing genotyping for the COGS collaboration. Genotypes were called using Illumina's proprietary GenCall algorithm. Pan-COGS initiatives were employed across experiments to optimize the calling algorithms for the iCOGS array. First, initial calling employed a cluster file generated using samples from HapMap 2. Second, a cluster file based on 3,018 individuals selected across genotyping centers, across participating consortia and across ancestry groups, combined with 380 samples of European, Asian or African ancestry genotyped as part of the HapMap and 1000 Genomes projects, was applied to call the genotypes for the subsequent samples. Third, the performance of GenCall was compared to that of two other calling algorithms: Illuminus54 and GenoSNP55. All three algorithms were >99% concordant in their calling for 91% of the SNPs on the array. Manual inspection of a sample of the discrepant SNPs indicated that the calls by GenCall were almost invariably superior (because Illuminus54 and GenoSNP55 frequently attempted to call SNPs that clustered poorly) 12 .
Quality control. Using the full set of 211,155 SNPs on the iCOGS array, we applied quality control exclusions as follows for subjects, excluding (i) samples with overall call rate of <95% or low or high heterozygosity (P < 1 × 10 −6 ) (5 cases);
(ii) the sample with the lower call rate from pairs of 'cryptic' duplicates or related samples, identified using identity-by-state estimates based on data from 37,046 uncorrelated SNPs (7 cases); and (iii) ancestry outliers identified by multidimensional scaling that combined the iCOGS data with those for the CEU, JPT/CHB and YRI HapMap 2 populations using 37,046 uncorrelated markers, with individuals removed if they had >10% non-Western European ancestry (18 cases). We included 1,064 cases and 10,082 controls in the final analysis. We applied quality control exclusions as follows for SNPs, excluding those (i) with discrepant calls in more than 2% of duplicate samples across COGS consortia; (ii) with call rate of <95%, MAF of <1%, or call rate of <99% if MAF was 1-5%; or (iii) with deviation from Hardy-Weinberg equilibrium (P < 1 × 10 −5 in controls, P < 1 × 10 −12 in cases). After quality control exclusions were applied individually to case and control data, we included genotypes from 694 SNPs in subsequent analyses. We examined genotype intensity cluster plots manually for SNPs in each new region for which a genome-wide significant association was achieved.
Statistical analysis. For the 694 SNPs in the TGCT iCOGS replication experiment, we estimated the per-allele OR, with 1 degree of freedom, using logistic regression, adjusting for principal components as covariates. We generated eight principal components and examined reduction in the inflation factor using iterative combinations of principal components. Inclusion of principal components 1-6 achieved optimal reduction in inflation, with no further reduction achieved by incorporating additional principal components into the regression model. We found no significant difference in the point estimates of effect size when performing sensitivity analysis between the control groups used in the TGCT iCOGS replication experiment.
The inflation factor (λ) was derived by dividing the median of the lowest 90% of the 1-degree-of-freedom statistics by the 45th percentile of a 1-degreeof-freedom χ 2 distribution (0.357), using 36,879 uncorrelated SNPs selected to not include TGCT-associated SNPs. The inflation was converted to an equivalent inflation for a study with 1,000 cases and 1,000 controls (λ 1000 ): l l 1000 1 500
We excluded from further analysis the 54 SNPs lying within the 6 previously identified TGCT-associated loci, defining these LD blocks via Oxford recombination rates. We included the 640 remaining SNPs in the replication analysis.
Because the inflation factor in the GWAS data was modest (λ = 1.078, λ 1000 = 1.045), we did not adjust the analysis of the GWAS data. We obtained overall significance levels by combining the estimates from the GWAS (unadjusted) and the iCOGS replication (adjusted for principal components 1-6) using a fixed-effects meta-analysis, to derive a 1-degree-offreedom test, calculating an I 2 statistic to evaluate heterogeneity between the GWAS and replication. We used a P-value threshold of 5 × 10 −8 to denote genome-wide significance. Of note, we had previously examined the loci at 1q24.1 and 4q24 in our first GWAS replication experiment 3 : although there had been evidence of replication of these signals via TaqMan genotyping of 565 cases and 1,758 controls, these associations had previously not achieved genome-wide significance.
We also computed genotype-specific ORs (2 degrees of freedom) for the iCOGS replication, adjusted for principal components 1-6 (Supplementary Table 2 ). We assessed each SNP for dose response in the replication series by comparing 1-degree-of-freedom and 2-degrees-of-freedom logistic regression models, both adjusted for principal components 1-6, using a likelihood ratio test (evaluated using a significance threshold of P < 0.006 to account for nine tests). We tested for statistical interaction between SNPs predisposing to TGCT (the 9 new SNPs and the 8 previously published SNPs) by evaluating the effect of adding an interaction term to the regression model, with adjustment for stage, using a likelihood ratio test (with a significance threshold of P < 0.0003 to account for 144 tests).
We assessed for modification of the ORs by covariate phenotype and risk factors using a case-only analysis incorporating both GWAS and iCOGS replication data (unadjusted). We evaluated the effect of age on SNP genotype via polytomous regression: we divided cases by age at diagnosis into five ordinal categories and fitted maximum-likelihood multinomial logistic models, executed using the mlogit command in Stata12 (using a significance threshold of P < 0.006 to account for nine tests; Supplementary Tables 3-5) .
We identified variants within each LD block reported in the 1000 Genomes Project (r 2 > 0.8 and <200 kb from the sentinel SNP) and used HaploReg and ENCODE data to apply functional annotations relevant to the regulation of transcription, including (i) whether the variant lies in a region in which modification of histone proteins is suggestive of enhancer and other regulatory activity (H3K4me1 and H3K27ac histone modification) or promoter activity (H3K4me3 histone modification); (ii) whether the variant lies in a region where the chromatin is hypersensitive to cleavage by the DNase I enzyme (suggestive of a regulatory region); (iii) whether the variant lies in a region that binds to transcription factors (as assayed by chromatin immunoprecipitation with antibodies specific to the transcription factor followed by sequencing of the precipitated DNA (ChIP-seq)); or (iv) whether the variant affects a specific regulatory motif, as evaluated from position-weighted matrices assembled from TRANSFAC, JASPAR and protein-binding microarray experiments (Supplementary Table 6 ) 45, 46 .
We investigated associations of the 9 TGCT-associated SNPs with gene expression using Genevar, which includes gene expression profiling and genotypic data from 4 data sets: (i) lymphoblastoid cell lines (LCLs) from 726 HapMap individuals (HapMap 3); (ii) adipose, LCLs and skin collected from 856 healthy female twins from the MuTHER resource (MuTHER pilot Twin 1);
